Ameloblastoma: A multicentric study

Objective. The objective of this study was to supplement the current ameloblastoma database by reporting the clinicopathologic features of ameloblastoma from Asia and North America. Materials and Methods. Biopsy records of the participating institutes were reviewed for lesions diagnosed as ameloblas...

全面介紹

Saved in:
書目詳細資料
Main Authors: Kittipong Dhanuthai, Soranun Chantarangsu, Somsri Rojanawatsirivej, Ekarat Phattarataratip, Mark Darling, Linda Jackson-Boeters, Nasser Said-Al-Naief, Hong In Shin, Chang Hyeong An, Nguyen Thi Hong, Phan Huynh An, Watcharaporn Thosaporn, Aroonwan Lam-Ubol, Ajiravudh Subarnbhesaj
格式: 雜誌
出版: 2018
主題:
在線閱讀:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84862518967&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/51559
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
機構: Chiang Mai University
實物特徵
總結:Objective. The objective of this study was to supplement the current ameloblastoma database by reporting the clinicopathologic features of ameloblastoma from Asia and North America. Materials and Methods. Biopsy records of the participating institutes were reviewed for lesions diagnosed as ameloblastoma during the years 1993 to 2009. Slides were reclassified according to the World Health Organization Classification of Odontogenic Tumors in 2005. Clinical information and radiographic features were collected and analyzed. Results. The mean age of the patients ± SD was 38.27 ± 17.78 years; 662 patients (51.36%) were men. Mandible (84.26%) outnumbered maxilla and other locations combined in all countries. The number of multilocular radiolucencies (43.40%) was comparable with that of unilocular radiolucencies (42.04%). Follicular pattern was the most common histopathologic pattern (27.70%), followed by plexiform (21.10%) and unicystic pattern (20.71%), respectively. Conclusions. The clinicopathologic features of ameloblastomas in the present study show some similarities with previous studies; however, minor differences exist. © 2012 Elsevier Inc. All rights reserved.